<VariationArchive VariationID="833103" VariationName="NC_000001.11:g.(?_235662920)_(235782107_?)del" VariationType="Deletion" Accession="VCV000833103" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="818935" VariationID="833103">
      <GeneList>
        <Gene Symbol="LYST" FullName="lysosomal trafficking regulator" GeneID="1130" HGNC_ID="HGNC:1968" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q42.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="235661031" stop="235883713" display_start="235661031" display_stop="235883713" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="235824342" stop="236030219" display_start="235824342" display_stop="236030219" Strand="-" />
          </Location>
          <OMIM>606897</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000001.11:g.(?_235662920)_(235782107_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q42.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="235826220" innerStop="235945407" display_start="235826220" display_stop="235945407" variantLength="119188" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_235826220)_(235945407_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_235826220)_(235945407_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.11:g.(?_235662920)_(235782107_?)del AND Chédiak-Higashi syndrome" Accession="RCV001033562" Version="7">
        <ClassifiedConditionList TraitSetID="6432">
          <ClassifiedCondition DB="MedGen" ID="C0007965">Chédiak-Higashi syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-04-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6432" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1424" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Chédiak-Higashi syndrome</ElementValue>
                <XRef ID="Chediak-Higashi+Syndrome/1319" DB="Genetic Alliance" />
                <XRef ID="111396008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chediak-Higashi Syndrome</ElementValue>
                <XRef ID="NBK5188" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CHS</ElementValue>
                <XRef Type="MIM" ID="214500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6035" />
                <XRef ID="6035" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Chediak-Higashi syndrome (CHS) is characterized by partial oculocutaneous albinism, immunodeficiency, and a mild bleeding tendency. Approximately 85% of affected individuals develop the accelerated phase, or hemophagocytic lymphohistiocytosis, a life-threatening, hyperinflammatory condition. All affected individuals including adolescents and adults with atypical CHS and children with classic CHS who have successfully undergone allogenic hematopoietic stem cell transplantation (HSCT) develop neurologic findings during early adulthood.</Attribute>
                <XRef ID="NBK5188" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301751</ID>
                <ID Source="BookShelf">NBK5188</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="167" DB="Orphanet" />
              <XRef ID="C0007965" DB="MedGen" />
              <XRef ID="MONDO:0008963" DB="MONDO" />
              <XRef Type="MIM" ID="214500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2358125" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_000081.3_1_Deletion (exons 15-53)|MedGen:C0007965" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001196869" DateUpdated="2024-06-09" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the LYST protein. Other variant(s) that disrupt this region (Deletion of Exons 23-53) have been determined to be pathogenic (Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with LYST-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 15-53 of the LYST gene. The 5' boundary is likely confined to intron 14. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LYST" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_235826220)_(235945407_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0007965" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2358125" TraitType="Disease" MappingType="XRef" MappingValue="C0007965" MappingRef="MedGen">
        <MedGen CUI="C0007965" Name="Chédiak-Higashi syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

